chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure and shingles were not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     The company considered the vaccination failure to be unrelated to Shingles vaccine and Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine and Shingles vaccine.   Additional Information: GSK Receipt Date: 11-JAN-2025 This case was reported by a patient via interactive digital media. The patient had received both doses of shingles vaccine but after got shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, details regarding time to onset and laboratory confirmation of disease) is considered unrelated to GSK Shingles vaccine.
Age: 20.0
Sex: F
Vaccine: HPV9
Symptoms: Burkitt's lymphoma, Chemotherapy
Clinical narrative: Burkitt?s Lymphoma, Intensive Chemotherapy lasting approximately 3 months
Age: 65.0
Sex: F
Vaccine: CHIK
Symptoms: Arthralgia, Headache, Joint swelling, Pyrexia, Rash
Clinical narrative: On the date listed, rash all over back of ankles, swollen ankles, rash on arm joints.  Prior days, headaches, joint aches, fever 102 degrees.
Sex: U
Vaccine: HEP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: No other AE; HCP reporting a 12 year old patient initiated the series on 02/05/2021 and the second dose was not administered until 12/09/2024.; This spontaneous report was received from a physician and refers to a 12-year-old patient of unknown gender.   The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.   On 05-FEB-2021, the patient was vaccinated with the first dose of hepatitis B vaccine (recombinant) (RECOMBIVAX HB) intramuscular injection, administered for prophylaxis (strength, dose, lot #, expiry date, and route of administration were not provided). On 09-DEC-2024, the patient was vaccinated with the second dose of hepatitis B vaccine (recombinant) (RECOMBIVAX HB) intramuscular injection, administered for prophylaxis (strength, dose, lot #, expiry date, and route of administration were not provided) (Inappropriate schedule of product administration). The patient had not received the third dose or completed the series as of yet. No symptoms reported and no additional details provided. Confirmed no product or quality events to report. No other adverse event (AE) or product quality complaint (PQC) was reported.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Suspected vaccination failure; shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a 55-year-old patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (before the age of 50).   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: shingles). The outcome of the vaccination failure was not reported and the outcome of the shingles was not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     The company considered the vaccination failure to be unrelated to Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine.   Additional Information: GSK receipt date: 09-JAN-2025 This case was reported by a patient via interactive digital media. Patient stated that most likely, but he/she gotta use and shingles before 50 and got shingles shot and now he/she had it again at 55.  Patient said it was awful. This case was considered as suspected vaccination failure as details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, completion of primary vaccination schedule, time to onset of shingles and laboratory confirmation of disease) is considered unrelated to GSK vaccine Shingles vaccine.
Age: 43.0
Sex: F
Vaccine: HEPAB
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Late second dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 43-year-old female patient who received HAB (Twinrix) (batch number D4774, expiry date 12-SEP-2026) for prophylaxis.   Previously administered products included Twinrix (1st dose received on 12th August 2024).   On 02-JAN-2025, the patient received the 2nd dose of Twinrix. On 02-JAN-2025, an unknown time after receiving Twinrix, the patient experienced drug dose administration interval too long (Verbatim: Late second dose). The outcome of the drug dose administration interval too long was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 02-JAN-2025 Pharmacist called to verify when the 3rd dose of Twinrix should be administered if the first dose was administered on 12th August 2024 and the second dose on 2nd January 2025. The vaccine administration facility is the same as primary reporter. The patient received second dose of Twinrix, later than the recommended interval, which led to lengthening of vaccination schedule. The case is linked with case US2025000310, reported by the same reporter for husband.; Sender's Comments:  US-GSK-US2025000310:Same reporter/ Different patient (Husband case)
Age: 30.0
Sex: M
Vaccine: IPV, TDAP
Symptoms: Anxiety, Dizziness, Dyskinesia, Immediate post-injection reaction, Loss of consciousness
Clinical narrative: Anxiety, dizziness occurred immediately after 2nd vaccination (Boostrix) as the needle was retracted. He was advised to take a sip of his water, which he did  After drinking some water, he immediately rolled his head back and started to have leg jerking movements, such as a seizure event. This lasted about 5 seconds and we immediately called 911. He gained consciousness within a few seconds. He sat and elevated his feet, but he did not recall any of the events after the vaccine for about 2 minutes. He was very pale so we offered more water and chocolate and cookies EMT took over after about 5 minutes.
Age: 30.0
Sex: M
Vaccine: IPV, TDAP
Symptoms: Pallor, Posture abnormal, Seizure like phenomena
Clinical narrative: Anxiety, dizziness occurred immediately after 2nd vaccination (Boostrix) as the needle was retracted. He was advised to take a sip of his water, which he did  After drinking some water, he immediately rolled his head back and started to have leg jerking movements, such as a seizure event. This lasted about 5 seconds and we immediately called 911. He gained consciousness within a few seconds. He sat and elevated his feet, but he did not recall any of the events after the vaccine for about 2 minutes. He was very pale so we offered more water and chocolate and cookies EMT took over after about 5 minutes.
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: My son (age 6) received his 4th Moderna COVID vaccine (2024-2025 booster- 3-11- .25 ML) at about 5 pm at a local pharmacy. He has not had reactions to the vaccine before. At 11 pm he woke us up and was covered in full body hives. We gave him benedryl and took him to the emergency room. The benedryl helped and he got no further treatment in the emergency room. He took zyrtec for a few days until the hives were gone. Follow up with pediatrician and allergist suggests this was an immune reactions. They do not recommend avoiding vaccines in the future, but perhaps switching brands.
Age: 66.0
Sex: F
Vaccine: HEPA
Symptoms: Underdose
Clinical narrative: Patient was given a Pediactric dose of a Hepatitis A vaccine instead of the adult dose.
Age: 1.33
Sex: F
Vaccine: DTAPIPVHIB
Symptoms: Wrong product administered
Clinical narrative: Pentacel was given by mistake instead of ActHib. 15 month series includes Dtap, Hib, Pneumoconjugate. Daptacel, Pentacel, and Prevnar-20 were given.
Age: 0.67
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC13
Symptoms: Incorrect dose administered
Clinical narrative: Adult Hep B dose administered to pediatric patient instead of pediatric dose. No treatment needed. Outcome N/A.
Age: 69.0
Sex: M
Vaccine: PNC20
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Not an adverse event- just a duplicate shot- patient already received this shot in the past 11/19/2023
Age: 1.5
Sex: M
Vaccine: PNC20
Symptoms: Wrong product administered
Clinical narrative: MD ordered the wrong vaccine and it was administered to patient.
Age: 1.5
Sex: F
Vaccine: PNC20
Symptoms: Wrong product administered
Clinical narrative: MD ordered the wrong vaccine and it was administered to patient.
Age: 7.0
Sex: M
Vaccine: DTAP, IPV, MMRV
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: No adverse events - Dtap given to  7 year old patient instead of Tdap
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Facial paralysis
Clinical narrative: Right side of mouth drooping
Age: 83.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Acute respiratory failure, Areflexia, CSF culture negative, CSF glucose increased, CSF lactate decreased
Clinical narrative: 83 y.o. female with relevant past medical history of hypertension, hyperlipidemia and hypothyroidism presented to an OSH on 12/26 with complaint of significant lower extremity weakness. Pt was found to have AIDP, acute respiratory failure (extubated 1/5), and acute toxic metabolic encephalopathy, now s/p plasmapheresis (completed on 1/15) and cryoprecipitate (1/16) now presenting with incomplete tetraplegia with LE much more affected than UE. Admitted to  for AIDP on 1/17/2025. AIDP -consistent with GBS, especially given elevated CSF protein, absent DTRs and recent influenza and COVID vaccines about 1 month ago -CSF studies to date reviewed: -Protein 124.6, glucose 101 -Lactic acid 2.2 -WBC 1, RBC 1 -Gram stain no organisms, Cx NGTD -VDRL not detected -VZV, HSV, CMV, WNV, enterovirus PCR negative -KOH prep reveals no mycelia or yeast forms; ABF smear negative -Cytology revealed increased white cells with a few neutrophils, lymphocytes and many monocytes -Completed 5 sessions of plasmapheresis last on 1/15.
Age: 83.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: CSF protein increased, CSF red blood cell count positive, CSF white blood cell count negative, Clotting factor transfusion, Cytology abnormal
Clinical narrative: 83 y.o. female with relevant past medical history of hypertension, hyperlipidemia and hypothyroidism presented to an OSH on 12/26 with complaint of significant lower extremity weakness. Pt was found to have AIDP, acute respiratory failure (extubated 1/5), and acute toxic metabolic encephalopathy, now s/p plasmapheresis (completed on 1/15) and cryoprecipitate (1/16) now presenting with incomplete tetraplegia with LE much more affected than UE. Admitted to  for AIDP on 1/17/2025. AIDP -consistent with GBS, especially given elevated CSF protein, absent DTRs and recent influenza and COVID vaccines about 1 month ago -CSF studies to date reviewed: -Protein 124.6, glucose 101 -Lactic acid 2.2 -WBC 1, RBC 1 -Gram stain no organisms, Cx NGTD -VDRL not detected -VZV, HSV, CMV, WNV, enterovirus PCR negative -KOH prep reveals no mycelia or yeast forms; ABF smear negative -Cytology revealed increased white cells with a few neutrophils, lymphocytes and many monocytes -Completed 5 sessions of plasmapheresis last on 1/15.
Age: 83.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Cytomegalovirus test negative, Endotracheal intubation, Enterovirus test negative, Gram stain, Gram stain negative
Clinical narrative: 83 y.o. female with relevant past medical history of hypertension, hyperlipidemia and hypothyroidism presented to an OSH on 12/26 with complaint of significant lower extremity weakness. Pt was found to have AIDP, acute respiratory failure (extubated 1/5), and acute toxic metabolic encephalopathy, now s/p plasmapheresis (completed on 1/15) and cryoprecipitate (1/16) now presenting with incomplete tetraplegia with LE much more affected than UE. Admitted to  for AIDP on 1/17/2025. AIDP -consistent with GBS, especially given elevated CSF protein, absent DTRs and recent influenza and COVID vaccines about 1 month ago -CSF studies to date reviewed: -Protein 124.6, glucose 101 -Lactic acid 2.2 -WBC 1, RBC 1 -Gram stain no organisms, Cx NGTD -VDRL not detected -VZV, HSV, CMV, WNV, enterovirus PCR negative -KOH prep reveals no mycelia or yeast forms; ABF smear negative -Cytology revealed increased white cells with a few neutrophils, lymphocytes and many monocytes -Completed 5 sessions of plasmapheresis last on 1/15.
Age: 83.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Guillain-Barre syndrome, Herpes simplex test negative, Muscular weakness, Mycobacterium test negative, Plasmapheresis
Clinical narrative: 83 y.o. female with relevant past medical history of hypertension, hyperlipidemia and hypothyroidism presented to an OSH on 12/26 with complaint of significant lower extremity weakness. Pt was found to have AIDP, acute respiratory failure (extubated 1/5), and acute toxic metabolic encephalopathy, now s/p plasmapheresis (completed on 1/15) and cryoprecipitate (1/16) now presenting with incomplete tetraplegia with LE much more affected than UE. Admitted to  for AIDP on 1/17/2025. AIDP -consistent with GBS, especially given elevated CSF protein, absent DTRs and recent influenza and COVID vaccines about 1 month ago -CSF studies to date reviewed: -Protein 124.6, glucose 101 -Lactic acid 2.2 -WBC 1, RBC 1 -Gram stain no organisms, Cx NGTD -VDRL not detected -VZV, HSV, CMV, WNV, enterovirus PCR negative -KOH prep reveals no mycelia or yeast forms; ABF smear negative -Cytology revealed increased white cells with a few neutrophils, lymphocytes and many monocytes -Completed 5 sessions of plasmapheresis last on 1/15.
Age: 83.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Potassium hydroxide preparation negative, Quadriplegia, Toxic encephalopathy, Treponema test negative, Varicella virus test negative
Clinical narrative: 83 y.o. female with relevant past medical history of hypertension, hyperlipidemia and hypothyroidism presented to an OSH on 12/26 with complaint of significant lower extremity weakness. Pt was found to have AIDP, acute respiratory failure (extubated 1/5), and acute toxic metabolic encephalopathy, now s/p plasmapheresis (completed on 1/15) and cryoprecipitate (1/16) now presenting with incomplete tetraplegia with LE much more affected than UE. Admitted to  for AIDP on 1/17/2025. AIDP -consistent with GBS, especially given elevated CSF protein, absent DTRs and recent influenza and COVID vaccines about 1 month ago -CSF studies to date reviewed: -Protein 124.6, glucose 101 -Lactic acid 2.2 -WBC 1, RBC 1 -Gram stain no organisms, Cx NGTD -VDRL not detected -VZV, HSV, CMV, WNV, enterovirus PCR negative -KOH prep reveals no mycelia or yeast forms; ABF smear negative -Cytology revealed increased white cells with a few neutrophils, lymphocytes and many monocytes -Completed 5 sessions of plasmapheresis last on 1/15.
Age: 83.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: West Nile virus test negative
Clinical narrative: 83 y.o. female with relevant past medical history of hypertension, hyperlipidemia and hypothyroidism presented to an OSH on 12/26 with complaint of significant lower extremity weakness. Pt was found to have AIDP, acute respiratory failure (extubated 1/5), and acute toxic metabolic encephalopathy, now s/p plasmapheresis (completed on 1/15) and cryoprecipitate (1/16) now presenting with incomplete tetraplegia with LE much more affected than UE. Admitted to  for AIDP on 1/17/2025. AIDP -consistent with GBS, especially given elevated CSF protein, absent DTRs and recent influenza and COVID vaccines about 1 month ago -CSF studies to date reviewed: -Protein 124.6, glucose 101 -Lactic acid 2.2 -WBC 1, RBC 1 -Gram stain no organisms, Cx NGTD -VDRL not detected -VZV, HSV, CMV, WNV, enterovirus PCR negative -KOH prep reveals no mycelia or yeast forms; ABF smear negative -Cytology revealed increased white cells with a few neutrophils, lymphocytes and many monocytes -Completed 5 sessions of plasmapheresis last on 1/15.
Age: 64.0
Sex: F
Vaccine: TDAP
Symptoms: Arthralgia, Atrial fibrillation, Dizziness, Dyspnoea, Electrocardiogram
Clinical narrative: Patient had constant sore left arm with throbbing with shooting pains from the left elbow to the wrist and fingers ("feels like a lightning bolt"), arm feels like it is bruised and aching ("like someone punched you in the arm that never stops"), sore all the way around her arm at the injection site (anterior and posterior), dizziness, went into Atrial Fibrillation on 12/8/2024, still has dizziness and at times has increased heart rate and shortness of air without any exertion, just feels unwell.
Age: 64.0
Sex: F
Vaccine: TDAP
Symptoms: Heart rate increased, Injection site pain, Malaise, Pain, Pain in extremity
Clinical narrative: Patient had constant sore left arm with throbbing with shooting pains from the left elbow to the wrist and fingers ("feels like a lightning bolt"), arm feels like it is bruised and aching ("like someone punched you in the arm that never stops"), sore all the way around her arm at the injection site (anterior and posterior), dizziness, went into Atrial Fibrillation on 12/8/2024, still has dizziness and at times has increased heart rate and shortness of air without any exertion, just feels unwell.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram venography head, Macrocytosis, Venogram abnormal
Clinical narrative: Left transverse sinus, sigmoid sinus, and jugular vein show small caliber and intraluminal filling defect noted consistent with chronic thrombus.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Brain natriuretic peptide increased, C-reactive protein increased, COVID-19, COVID-19 pneumonia
Clinical narrative: BRIEF OVERVIEW: Admission Date: 1/14/2025 Discharge Date: Jan 16, 2025 Discharge Disposition:  home health care svc  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypocalcemia [E83.51] Elevated C-reactive protein (CRP) [R79.82] Elevated sed rate [R70.0] Hypoxia [R09.02] Elevated troponin [R79.89] Atrial fibrillation with RVR [I48.91] Elevated brain natriuretic peptide (BNP) level [R79.89] Diabetic ulcer of toe of right foot associated with diabetes mellitus of other type, unspecified ulcer stage [E13.621, L97.519] Acute on chronic congestive heart failure, unspecified heart failure type [I50.9] Hyperglycemia due to diabetes mellitus  [E11.65] Pneumonia due to COVID-19 virus [U07.1, J12.82] COVID-19 [U07.1] COVID [U07.1]  HOSPITAL COURSE:  Patient is a 67-year-old male history of diabetes, diabetic neuropathy, peripheral vascular disease status post left AKA, coronary artery disease, AFib on Xarelto, depression anxiety and chronic pain.  Presents for chief complaint of cough shortness for breath chest pain.  Admission EKGs chronic AFib without ST segment or T-wave changes.  Troponins were noted to be elevated with negative delta likely related to demand ischemia from hypoxia.  Patient was on 2 L at admission febrile.  RVP was obtained and positive for COVID-19.  Patient was started on remdesivir and Decadron for COVID treatment.  Initially requiring supplemental oxygen titrated to room air.  Patient was complete course of steroids at discharge.  During stay patient was noted to have right 1st toe chronic wound.  He was seen by wound care team without obvious signs of infection although some concern for long-term healing.  Patient was not seen Cardiothoracic surgery in 3-4 years she will be referred on outpatient basis for further workup.  We will follow up with wound care team and have home health for wound nursing.  Patient was recurrent episodes of chest pain during his stay all associated with morning meals and self resolving.  EKGs were obtained and normal at those times likely deemed related to viral syndrome versus GI based.  Discharged to Home Health Services
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac failure acute, Cardiac failure congestive, Chest pain, Condition aggravated, Cough
Clinical narrative: BRIEF OVERVIEW: Admission Date: 1/14/2025 Discharge Date: Jan 16, 2025 Discharge Disposition:  home health care svc  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypocalcemia [E83.51] Elevated C-reactive protein (CRP) [R79.82] Elevated sed rate [R70.0] Hypoxia [R09.02] Elevated troponin [R79.89] Atrial fibrillation with RVR [I48.91] Elevated brain natriuretic peptide (BNP) level [R79.89] Diabetic ulcer of toe of right foot associated with diabetes mellitus of other type, unspecified ulcer stage [E13.621, L97.519] Acute on chronic congestive heart failure, unspecified heart failure type [I50.9] Hyperglycemia due to diabetes mellitus  [E11.65] Pneumonia due to COVID-19 virus [U07.1, J12.82] COVID-19 [U07.1] COVID [U07.1]  HOSPITAL COURSE:  Patient is a 67-year-old male history of diabetes, diabetic neuropathy, peripheral vascular disease status post left AKA, coronary artery disease, AFib on Xarelto, depression anxiety and chronic pain.  Presents for chief complaint of cough shortness for breath chest pain.  Admission EKGs chronic AFib without ST segment or T-wave changes.  Troponins were noted to be elevated with negative delta likely related to demand ischemia from hypoxia.  Patient was on 2 L at admission febrile.  RVP was obtained and positive for COVID-19.  Patient was started on remdesivir and Decadron for COVID treatment.  Initially requiring supplemental oxygen titrated to room air.  Patient was complete course of steroids at discharge.  During stay patient was noted to have right 1st toe chronic wound.  He was seen by wound care team without obvious signs of infection although some concern for long-term healing.  Patient was not seen Cardiothoracic surgery in 3-4 years she will be referred on outpatient basis for further workup.  We will follow up with wound care team and have home health for wound nursing.  Patient was recurrent episodes of chest pain during his stay all associated with morning meals and self resolving.  EKGs were obtained and normal at those times likely deemed related to viral syndrome versus GI based.  Discharged to Home Health Services
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Diabetic foot, Dyspnoea, Electrocardiogram abnormal, Gastrointestinal disorder, Hyperglycaemia
Clinical narrative: BRIEF OVERVIEW: Admission Date: 1/14/2025 Discharge Date: Jan 16, 2025 Discharge Disposition:  home health care svc  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypocalcemia [E83.51] Elevated C-reactive protein (CRP) [R79.82] Elevated sed rate [R70.0] Hypoxia [R09.02] Elevated troponin [R79.89] Atrial fibrillation with RVR [I48.91] Elevated brain natriuretic peptide (BNP) level [R79.89] Diabetic ulcer of toe of right foot associated with diabetes mellitus of other type, unspecified ulcer stage [E13.621, L97.519] Acute on chronic congestive heart failure, unspecified heart failure type [I50.9] Hyperglycemia due to diabetes mellitus  [E11.65] Pneumonia due to COVID-19 virus [U07.1, J12.82] COVID-19 [U07.1] COVID [U07.1]  HOSPITAL COURSE:  Patient is a 67-year-old male history of diabetes, diabetic neuropathy, peripheral vascular disease status post left AKA, coronary artery disease, AFib on Xarelto, depression anxiety and chronic pain.  Presents for chief complaint of cough shortness for breath chest pain.  Admission EKGs chronic AFib without ST segment or T-wave changes.  Troponins were noted to be elevated with negative delta likely related to demand ischemia from hypoxia.  Patient was on 2 L at admission febrile.  RVP was obtained and positive for COVID-19.  Patient was started on remdesivir and Decadron for COVID treatment.  Initially requiring supplemental oxygen titrated to room air.  Patient was complete course of steroids at discharge.  During stay patient was noted to have right 1st toe chronic wound.  He was seen by wound care team without obvious signs of infection although some concern for long-term healing.  Patient was not seen Cardiothoracic surgery in 3-4 years she will be referred on outpatient basis for further workup.  We will follow up with wound care team and have home health for wound nursing.  Patient was recurrent episodes of chest pain during his stay all associated with morning meals and self resolving.  EKGs were obtained and normal at those times likely deemed related to viral syndrome versus GI based.  Discharged to Home Health Services
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Hypocalcaemia, Hypoxia, Myocardial ischaemia, Pyrexia, Red blood cell sedimentation rate increased
Clinical narrative: BRIEF OVERVIEW: Admission Date: 1/14/2025 Discharge Date: Jan 16, 2025 Discharge Disposition:  home health care svc  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypocalcemia [E83.51] Elevated C-reactive protein (CRP) [R79.82] Elevated sed rate [R70.0] Hypoxia [R09.02] Elevated troponin [R79.89] Atrial fibrillation with RVR [I48.91] Elevated brain natriuretic peptide (BNP) level [R79.89] Diabetic ulcer of toe of right foot associated with diabetes mellitus of other type, unspecified ulcer stage [E13.621, L97.519] Acute on chronic congestive heart failure, unspecified heart failure type [I50.9] Hyperglycemia due to diabetes mellitus  [E11.65] Pneumonia due to COVID-19 virus [U07.1, J12.82] COVID-19 [U07.1] COVID [U07.1]  HOSPITAL COURSE:  Patient is a 67-year-old male history of diabetes, diabetic neuropathy, peripheral vascular disease status post left AKA, coronary artery disease, AFib on Xarelto, depression anxiety and chronic pain.  Presents for chief complaint of cough shortness for breath chest pain.  Admission EKGs chronic AFib without ST segment or T-wave changes.  Troponins were noted to be elevated with negative delta likely related to demand ischemia from hypoxia.  Patient was on 2 L at admission febrile.  RVP was obtained and positive for COVID-19.  Patient was started on remdesivir and Decadron for COVID treatment.  Initially requiring supplemental oxygen titrated to room air.  Patient was complete course of steroids at discharge.  During stay patient was noted to have right 1st toe chronic wound.  He was seen by wound care team without obvious signs of infection although some concern for long-term healing.  Patient was not seen Cardiothoracic surgery in 3-4 years she will be referred on outpatient basis for further workup.  We will follow up with wound care team and have home health for wound nursing.  Patient was recurrent episodes of chest pain during his stay all associated with morning meals and self resolving.  EKGs were obtained and normal at those times likely deemed related to viral syndrome versus GI based.  Discharged to Home Health Services
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory viral panel, SARS-CoV-2 test positive, Troponin increased, Viral infection
Clinical narrative: BRIEF OVERVIEW: Admission Date: 1/14/2025 Discharge Date: Jan 16, 2025 Discharge Disposition:  home health care svc  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypocalcemia [E83.51] Elevated C-reactive protein (CRP) [R79.82] Elevated sed rate [R70.0] Hypoxia [R09.02] Elevated troponin [R79.89] Atrial fibrillation with RVR [I48.91] Elevated brain natriuretic peptide (BNP) level [R79.89] Diabetic ulcer of toe of right foot associated with diabetes mellitus of other type, unspecified ulcer stage [E13.621, L97.519] Acute on chronic congestive heart failure, unspecified heart failure type [I50.9] Hyperglycemia due to diabetes mellitus  [E11.65] Pneumonia due to COVID-19 virus [U07.1, J12.82] COVID-19 [U07.1] COVID [U07.1]  HOSPITAL COURSE:  Patient is a 67-year-old male history of diabetes, diabetic neuropathy, peripheral vascular disease status post left AKA, coronary artery disease, AFib on Xarelto, depression anxiety and chronic pain.  Presents for chief complaint of cough shortness for breath chest pain.  Admission EKGs chronic AFib without ST segment or T-wave changes.  Troponins were noted to be elevated with negative delta likely related to demand ischemia from hypoxia.  Patient was on 2 L at admission febrile.  RVP was obtained and positive for COVID-19.  Patient was started on remdesivir and Decadron for COVID treatment.  Initially requiring supplemental oxygen titrated to room air.  Patient was complete course of steroids at discharge.  During stay patient was noted to have right 1st toe chronic wound.  He was seen by wound care team without obvious signs of infection although some concern for long-term healing.  Patient was not seen Cardiothoracic surgery in 3-4 years she will be referred on outpatient basis for further workup.  We will follow up with wound care team and have home health for wound nursing.  Patient was recurrent episodes of chest pain during his stay all associated with morning meals and self resolving.  EKGs were obtained and normal at those times likely deemed related to viral syndrome versus GI based.  Discharged to Home Health Services
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Axillary pain, Bundle branch block right, Electrocardiogram abnormal, Injection site mass
Clinical narrative: pt says her left arm became very sore and developed a lump around the injection site. The soreness started to move into the armpit and down into the elbow. It continued to get worse so she went to Urgent Care. They did an Xray and EKG. Xray was negative. The EKG showed some right bundle branch block. She was told to follow up with cardiologist. She was referred to an Orthopedic doctor for a suspected shoulder sprain or rotator cuff injury. She went to Ortho Dr. She was given 2 cortisone shots in the left shoulder. She is suspected to have a torn rotator cuff that is possibily turning into a frozen shoulder and was prescribed physical therapy. She will start on Feb 5th. She is scheduled to have a MRI and will FU w/ Ortho Dr. on Jan 29th  after MRI.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Ligament sprain, Pain in extremity, Rotator cuff syndrome, X-ray normal
Clinical narrative: pt says her left arm became very sore and developed a lump around the injection site. The soreness started to move into the armpit and down into the elbow. It continued to get worse so she went to Urgent Care. They did an Xray and EKG. Xray was negative. The EKG showed some right bundle branch block. She was told to follow up with cardiologist. She was referred to an Orthopedic doctor for a suspected shoulder sprain or rotator cuff injury. She went to Ortho Dr. She was given 2 cortisone shots in the left shoulder. She is suspected to have a torn rotator cuff that is possibily turning into a frozen shoulder and was prescribed physical therapy. She will start on Feb 5th. She is scheduled to have a MRI and will FU w/ Ortho Dr. on Jan 29th  after MRI.
Age: 1.25
Sex: M
Vaccine: FLUN3
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Pt given Flumist 7 months to early. No actual adverse effects. Pt on 1 year 3 months.
Age: 12.0
Sex: M
Vaccine: FLU3, HPV9
Symptoms: No adverse event
Clinical narrative: There was no reaction to the vaccine
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Electrocardiogram, Expired product administered
Clinical narrative: Covid vaccine expired. Chest pain 2 minutes after receiving vaccine
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: CSF protein increased, Computerised tomogram, Hypoaesthesia, Magnetic resonance imaging
Clinical narrative: i started losing feeling in my arms and legs shortly after my covid vaccine
Age: 80.0
Sex: M
Vaccine: PNC21
Symptoms: Arthralgia, Cough, Malaise, Myalgia
Clinical narrative: GENERAL MALAISE, COUGHING, WHOLE BODY MUSCLES AND JOINTS SORENESS.
Age: 0.17
Sex: M
Vaccine: PNC20
Symptoms: Pyrexia, Supraventricular tachycardia
Clinical narrative: Patient received Prevnar 20 on Jan 14, 2025.  On 1/15, patient had fever induced SVT requiring adenosine, acetaminophen, and ice packs.  Once the fever came down, so did the HR
Age: 90.0
Sex: F
Vaccine: PNC20
Symptoms: No adverse event
Clinical narrative: No adverse events noted
Age: 12.0
Sex: F
Vaccine: HPV9
Symptoms: Abdominal distension, Eczema, Eczema eyelids, Rash erythematous, Rash pruritic
Clinical narrative: Came back home on 12/21/2024, received MMR#2 (MMR-II), Tdap (Adacel) and IPV#5 in left upper arm at HC on 12/24/2024 without reaction. On 1/06/2025 received MCV (Menveo) and HPV (Gardasil 9) in left upper arm, developed swelling in left upper arm along with itchy red rash over shoulders, in folds of arms, wrists, over MCPs of hands, upper eyelids and flexural ankles. Patient started over-the-counter Benadryl 25mg tab oral and hydrocortisone 1% cream since 1/06 without relief. Constantly itching, picked red bumps over wrists. Never has had a history of eczema in the past. Examined by MD on 1/23/25 and placed on tacrolimus 0.03% ointment for eyelid eczema; triamcinolone acetonide 0.1% ointment for flexural eczema and hydroxyzine 25mg oral tab QID PRN itching
Age: 0.33
Sex: M
Vaccine: DTPPVHBHPB, PNC20, RV5
Symptoms: Rash
Clinical narrative: Child awakened the day after the vaccines with a rash compatable with erythema multiforme.
Age: 21.0
Sex: F
Vaccine: UNK
Symptoms: Cough, Endotracheal intubation, Intensive care, Pallor, Throat tightness
Clinical narrative: WITHIN MINUTES OF RECEIVING FLU VACCINE, EMPLOYEE DEVELOPED A COUGH, ASKED FOR WATER, NO RELIEF, DEVELOPED AUDIBLE WHEEZING, CHEST AUSCULTAION BILAT WHEEZING ALL LOBES; EMPLOYEE COMPLAINED OF THROAT FEELING FEELING CONSTRICTING; COLOR PALE; EMPLOYEE HAD EPI-PEN WITH HER, GAVE IM RIGHT THIGH, CALLED EMS, TRANSPORTED TO ED. INTUBATED, ADMITTED OVERNIGHT TO INTENSIVE CARE.
Age: 21.0
Sex: F
Vaccine: UNK
Symptoms: Wheezing
Clinical narrative: WITHIN MINUTES OF RECEIVING FLU VACCINE, EMPLOYEE DEVELOPED A COUGH, ASKED FOR WATER, NO RELIEF, DEVELOPED AUDIBLE WHEEZING, CHEST AUSCULTAION BILAT WHEEZING ALL LOBES; EMPLOYEE COMPLAINED OF THROAT FEELING FEELING CONSTRICTING; COLOR PALE; EMPLOYEE HAD EPI-PEN WITH HER, GAVE IM RIGHT THIGH, CALLED EMS, TRANSPORTED TO ED. INTUBATED, ADMITTED OVERNIGHT TO INTENSIVE CARE.
Age: 8.0
Sex: M
Vaccine: IPV
Symptoms: Immediate post-injection reaction, Injection site reaction, Rash papular
Clinical narrative: Immediately following injection the injection site developed a raised round area 1 cm in diameter. Within 1-2 minutes a raised red rash developed from the injection site out to the side approximately and inch on each side and down the arm to the elbow.  Within 10 minutes the rash diminished to about half the size and was no longer raised.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Bacterial infection, Upper respiratory tract infection
Clinical narrative: Several weeks after vaccination, developed upper respiratory tract infection (COVID-19 negative) which then developed into a secondary bacterial infection. Unlikely to be related to vaccination.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19, PNC20
Symptoms: Underdose
Clinical narrative: Patient given pediatric dose of vaccine instead of adult strength vaccine.  Returned a few hours later to receive the adult dose of vaccine (only -.25 to make it collectively a full dose)
Age: 80.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Tendon injury
Clinical narrative: Patient reports tendon tear in the left arm starting two weeks after receiving the Covid vaccine
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Mobility decreased, Pain in extremity
Clinical narrative: relates that has had a reaction since day given. never reacted to a shot before. Denies redness, fever, illness relates Pain dsown arm is the reaction , DO NOT have full range of motion.  Been since I received shot.
Age: 61.0
Sex: M
Vaccine: COVID19, FLU3
Symptoms: Dyspnoea, Myasthenia gravis
Clinical narrative: After approximately 3 days, patient showed up to doctor's office complaining of difficulties breathing. He was diagnosed as having Myasthenia Gravis. He had no previous symptoms nor diagnoses of MG. It is unknown if the vaccine was a trigger, but given the disease mechanisms, it is possible that the vaccine(s) triggered an undiagnosed condition.
Age: 0.5
Sex: F
Vaccine: DTAP, HIBV, RV5
Symptoms: Aggression, Dyskinesia, Head banging, Strabismus
Clinical narrative: Baby started aggressively banging head on everything especially hard surfaces, began squinting eyes, and having whole body jerks
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Condition aggravated
Clinical narrative: Significant hair loss
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema
Clinical narrative: Redness to arm 2 weeks later, measuring 30x20cm
Age: 64.0
Sex: F
Vaccine: UNK
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: No adverse event took place but patient received vaccine for over 65 year old before reaching that age. Patient is only 64 years and 9 month old.
Age: 1.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Incorrect dose administered, Pyrexia
Clinical narrative: Patient was given a covid vaccine (Pfizer Comirnaty for age 12+) when he should have received the covid vaccine (Moderna for age 6m-11yr). Patient did develop a fever that night after receiving the wrong vaccine for his age.
Age: 1.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Full blood count, Overdose, Product administered to patient of inappropriate age, Pyrexia
Clinical narrative: Patient was given a covid vaccine (Pfizer Comirnaty for age 12+) when he should have received the covid vaccine (Moderna for age 6m-11yr). Patient did develop a fever that night after receiving the wrong vaccine for his age.
Age: 4.0
Sex: F
Vaccine: DTAPIPVHIB, MMRV
Symptoms: Wrong product administered
Clinical narrative: Pt received incorrect vaccine, Quadracel ordered, but pentacel given which is not accurate product for patient's need.
Age: 3.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product administered to patient of inappropriate age, Pyrexia
Clinical narrative: Patient was given a covid vaccine (Pfizer Comirnaty for age 12+) when she should have received the covid vaccine (Moderna for age 6m-11yr). Patient did develop a fever that night after receiving the wrong vaccine for her age.
Age: 3.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Overdose, Product administered to patient of inappropriate age, Pyrexia
Clinical narrative: Patient was given a covid vaccine (Pfizer Comirnaty for age 12+) when she should have received the covid vaccine (Moderna for age 6m-11yr). Patient did develop a fever that night after receiving the wrong vaccine for her age.
Age: 10.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Alopecia, Condition aggravated
Clinical narrative: Excessive hair loss
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Head injury, Seizure like phenomena, Syncope
Clinical narrative: PATIENT HAD WHAT LOOKED LIKE A SEIZURE BEFORE FAINTING AND HITTING HER HEAD.
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: This vaccine was beyond use date. Vaccine was being stored in refrigerator between temperatures of 36-46 degrees Fahrenheit, which means this vaccine is good for 10 weeks after receiving it.  Date would have been 12/25/2024
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Eschar, Injection site erythema, Injection site oedema, Injection site rash, Injection site reaction
Clinical narrative: Left deltoid superior aspect with small eschar and no local redness, inferior aspect of deltoid, small eschar with local redness and mild edema, pink/violaceous irregular rash inferior  to deltoid but congrunet with inferior injection site.  Superficial tactile sensitivy but no significant induration, no soft tissue or bony defect.  Distal to mid portion of upper arm is slightly pale lacey purplish/mottled area.  Distal forearm and hand normal.  Notes: MCV-4 appears to be the presumed trigger for this fixed local reaction. It's expected to diffuse in the next 3-4 days. May migrate with gravity. May treat locally with ice/heat if needed, may continue experience sensory sensitivity of skin until rash is resolved. Discussed okay to tentatively plan to repeat vaccine when due at 16 years. Fixed local reaction does not appear to be in the spectrum of allergy with risk of systemic allergy or dangerous consequences. Patient is uniquie in circumstances as his liklihood of reaction may be a reflection of the pooled immunoglobulin he gets for his hypogammaglobulinemia. May address with Immunologist if parents wish. VAERS report to be filed.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Livedo reticularis, Sensitive skin
Clinical narrative: Left deltoid superior aspect with small eschar and no local redness, inferior aspect of deltoid, small eschar with local redness and mild edema, pink/violaceous irregular rash inferior  to deltoid but congrunet with inferior injection site.  Superficial tactile sensitivy but no significant induration, no soft tissue or bony defect.  Distal to mid portion of upper arm is slightly pale lacey purplish/mottled area.  Distal forearm and hand normal.  Notes: MCV-4 appears to be the presumed trigger for this fixed local reaction. It's expected to diffuse in the next 3-4 days. May migrate with gravity. May treat locally with ice/heat if needed, may continue experience sensory sensitivity of skin until rash is resolved. Discussed okay to tentatively plan to repeat vaccine when due at 16 years. Fixed local reaction does not appear to be in the spectrum of allergy with risk of systemic allergy or dangerous consequences. Patient is uniquie in circumstances as his liklihood of reaction may be a reflection of the pooled immunoglobulin he gets for his hypogammaglobulinemia. May address with Immunologist if parents wish. VAERS report to be filed.
Age: 27.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Arthralgia, Bone marrow oedema, Immediate post-injection reaction, Magnetic resonance imaging joint
Clinical narrative: L shoulder pain immediately after vaccine administration and chronically for months following.
Age: 32.0
Sex: F
Vaccine: FLU3
Symptoms: Extra dose administered, No adverse event
Clinical narrative: The nursing assistant gave a second flu shot to this member. No adverse effects.
Age: 2.0
Sex: M
Vaccine: DTAPIPV
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: No adverse reactions.
Age: 21.0
Sex: F
Vaccine: HPV9
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient received 3rd dose of HPV, when only needed the 2 dose series. No symptoms or side effects noted.
Age: 44.0
Sex: M
Vaccine: FLU3
Symptoms: Arthralgia, Asthenia, Chest X-ray, Chest discomfort, Chest pain
Clinical narrative: Patient presented to ER at outlying facility complaining of chest pain, vision changes (tunnel vision), ears ringing, near syncope, dizziness, pale, clammy,  flushing of skin, chest tightness, weak, sluggish, and fatigue. He was evaluated at ER on 1/16/25 and everything on exam reported to be benign. Patient has since followed up with us to be evaluated by his PCP on 1/17/25 and again 1/24/25 and is still continuing to have lingering symptoms, reporting lightheaded, joint pain, shaky, dizzy, nausea, decreased appetite, and difficulty sleeping. PCP Dr. is suspicious this is post influenza vaccination reaction with neurological involvement and encephalopathy. We will continue to follow up with patient and his symptoms.
Age: 44.0
Sex: M
Vaccine: FLU3
Symptoms: Cold sweat, Decreased appetite, Dizziness, Electrocardiogram, Fatigue
Clinical narrative: Patient presented to ER at outlying facility complaining of chest pain, vision changes (tunnel vision), ears ringing, near syncope, dizziness, pale, clammy,  flushing of skin, chest tightness, weak, sluggish, and fatigue. He was evaluated at ER on 1/16/25 and everything on exam reported to be benign. Patient has since followed up with us to be evaluated by his PCP on 1/17/25 and again 1/24/25 and is still continuing to have lingering symptoms, reporting lightheaded, joint pain, shaky, dizzy, nausea, decreased appetite, and difficulty sleeping. PCP Dr. is suspicious this is post influenza vaccination reaction with neurological involvement and encephalopathy. We will continue to follow up with patient and his symptoms.
Age: 44.0
Sex: M
Vaccine: FLU3
Symptoms: Flushing, Full blood count, Influenza virus test, Insomnia, Metabolic function test
Clinical narrative: Patient presented to ER at outlying facility complaining of chest pain, vision changes (tunnel vision), ears ringing, near syncope, dizziness, pale, clammy,  flushing of skin, chest tightness, weak, sluggish, and fatigue. He was evaluated at ER on 1/16/25 and everything on exam reported to be benign. Patient has since followed up with us to be evaluated by his PCP on 1/17/25 and again 1/24/25 and is still continuing to have lingering symptoms, reporting lightheaded, joint pain, shaky, dizzy, nausea, decreased appetite, and difficulty sleeping. PCP Dr. is suspicious this is post influenza vaccination reaction with neurological involvement and encephalopathy. We will continue to follow up with patient and his symptoms.
Age: 44.0
Sex: M
Vaccine: FLU3
Symptoms: Nausea, Nervousness, Pallor, Respiratory syncytial virus test, SARS-CoV-2 test
Clinical narrative: Patient presented to ER at outlying facility complaining of chest pain, vision changes (tunnel vision), ears ringing, near syncope, dizziness, pale, clammy,  flushing of skin, chest tightness, weak, sluggish, and fatigue. He was evaluated at ER on 1/16/25 and everything on exam reported to be benign. Patient has since followed up with us to be evaluated by his PCP on 1/17/25 and again 1/24/25 and is still continuing to have lingering symptoms, reporting lightheaded, joint pain, shaky, dizzy, nausea, decreased appetite, and difficulty sleeping. PCP Dr. is suspicious this is post influenza vaccination reaction with neurological involvement and encephalopathy. We will continue to follow up with patient and his symptoms.
Age: 44.0
Sex: M
Vaccine: FLU3
Symptoms: Sluggishness, Syncope, Tinnitus, Troponin, Tunnel vision
Clinical narrative: Patient presented to ER at outlying facility complaining of chest pain, vision changes (tunnel vision), ears ringing, near syncope, dizziness, pale, clammy,  flushing of skin, chest tightness, weak, sluggish, and fatigue. He was evaluated at ER on 1/16/25 and everything on exam reported to be benign. Patient has since followed up with us to be evaluated by his PCP on 1/17/25 and again 1/24/25 and is still continuing to have lingering symptoms, reporting lightheaded, joint pain, shaky, dizzy, nausea, decreased appetite, and difficulty sleeping. PCP Dr. is suspicious this is post influenza vaccination reaction with neurological involvement and encephalopathy. We will continue to follow up with patient and his symptoms.